Epharmix

St. Louis, United States Founded: 2015 • Age: 11 yrs
Provider of a platform offering communication tools to healthcare providers

About Epharmix

Epharmix is a company based in St. Louis (United States) founded in 2015. Epharmix has raised $1.88 million across 4 funding rounds from investors including Arch Grants, HealthX Ventures and BioGenerator. Epharmix operates in a competitive market with competitors including Slack, RingCentral, Fuze, Webex and Weave, among others.

  • Headquarter St. Louis, United States
  • Sectors
    Healthcare
    Technology
  • Website epharmix.com
  • Social LinkedIn
  • Legal Name Epharmix, Inc.
Key Metrics
  • Total Equity Funding
    $1.88M (USD)

    in 4 rounds

  • Latest Funding Round
    $1.88M (USD), Seed

    May 2018

  • Investors

Funding Insights of Epharmix

Epharmix has successfully raised a total of $1.88M across 4 strategic funding rounds. The most recent funding activity was a Seed round of $1.88 million completed in May 2018. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.

  • Total Funding $1.88M
  • Total Rounds 4
  • Last Round Seed β€” $1.88M
  • First Round $765,000

    (Jul 2015)

  • Investors Count 3

All 4 funding rounds of Epharmix with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
May 2018$1.88MSeed––
–
Nov 2017$50,000Grant––
Oct 2016–Seed––
Jul 2015$765,000Debt – Conventional––
Valuation history

3 investors in total: 3 institutional.

Investors in Epharmix

Epharmix has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Arch Grants, HealthX Ventures and BioGenerator.

All
Venture Fund
InvestorDescriptionFounded YearDomainLocation
A 12-month accelerator program is offered to tech startups.
2011archgrants.orgSt. Louis, United States
Investments are directed toward accessible digital healthcare solutions.
–healthxventures.comMadison, United States
BioGenerator is engaged in investing in life sciences startups.
–biogenerator.orgSt. Louis, United States
Premium access

Investor details for Epharmix

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of Epharmix

18 people are tracked at Epharmix (1 in leadership, 17 in team).

NameRoleGroup
Christine Stavridis
Creative DirectorLeadership
Levi Kaip
Senior Solutions EngineerTeam
Charlee K McCormick
Marketing Campaign CoordinatorTeam
Jolene Talamantez
Engagement SpecialistTeam
Connor Loesing, MHA
Strategic Account ManagerTeam
Hellen Dang
Account ManagerTeam
Katie Hare
Account ManagerTeam
Remy Javed
Business DevelopmentTeam
Matt Craven
Business Development SpecialistTeam
Richard Xie
Project ManagerTeam
Karen Williams-Davis
Patient Engagement SpecialistTeam
Lauren Howard
Customer Success ManagerTeam
Siri Athota
Product ManagerTeam
John Kayl Thomas
Software EngineerTeam
Olivia Davis
Software EngineerTeam
Jason Roche
Growth EngineerTeam
Alexander Gool
Software EngineerTeam
Nathan Beck
Software Engineering ManagerTeam
Premium access

Complete people profiles for Epharmix

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Timeline of Epharmix

3 dated milestones of Epharmix across 3 years, from founding to its latest funding, stage changes and deals.

  1. Founded Epharmix is founded.
  2. Funding First funding round of $765K.
  3. Funding Latest funding round, Seed, of $1.9M.

Competitors of Epharmix

Epharmix operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Slack, RingCentral, Fuze, Webex and Weave, among others.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
slack.com2009San Francisco, United States$1.22B1,820
Cloud-based team communication and collaboration platform is provided.
ringcentral.com1999Belmont, United States$44M4,084
Cloud-based unified communication solutions are offered to diverse sectors.
fuze.com2006Boston, United States$542.81M771
Fuze, under 8x8, Inc., is recognized for providing cloud-based communication and customer experience solutions.
webex.com1995San Jose, United States$25M26,200
Solutions for virtual meetings and training sessions are provided.
getweave.com2008Provo, United States$156.09M922
Omnichannel software is delivered for customer engagement in healthcare businesses.
mitel.com1973Ottawa, Canada$1.01M430
Unified communication platforms are managed via cloud-based systems.
lumapps.com2012–$102M–
Cloud-based employee communication platform is provided for internal collaboration.
vonage.com2001Holmdel, United States$642.33M1,089
Provider of contact center business communication solutions
bandwidth.com1999Raleigh, United States$21.89M1,939
VoIP communication management is facilitated via a cloud-based enterprise platform.
loom.com1944San Francisco, United States$214.23M–
Video based communication solution
Premium access

Detailed competitors of Epharmix

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Epharmix

Premium access

Complete news archive for Epharmix

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Similar companies to Epharmix

10 companies that operate in the same segment as Epharmix (Clinical IT & Data Platforms), ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Provider of fitness memberships encompassing group classes, gyms, and at-home workouts
2016Bengaluru, Karnataka, IndiaUSD 713.57 M––
Employee health benefits are facilitated via a cloud-based platform.
2007Plymouth Meeting, Pennsylvania, United StatesUSD 228.3 M––
Healthcare appointments are booked online via Zocdoc's platform.
2007New York, New York, United StatesUSD 425.97 MUSD 4.66 M233
Virtual physical therapy and digital pain care solutions are provided.
2015San Francisco, California, United StatesUSD 854.44 M––
Tech-enabled mental health solutions for employers are provided.
2016New York, New York, United StatesUSD 508.73 M––
App-based health insurance is offered to individuals and businesses.
2016Paris, FranceUSD 863.12 M––
Virtual care programs for managing chronic diseases are provided.
2011San Francisco, California, United StatesUSD 450.12 MUSD 260.21 M–
AI-driven EMR and practice management software is delivered for clinics.
2010Boca Raton, Florida, United StatesUSD 329.17 M––
Cloud-based administrative tools for healthcare providers are offered.
1997Watertown, United StatesUSD 40 M––
Membership-based primary care platform is offered for employees and consumers.
2007San Francisco, California, United StatesUSD 402.56 M––
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Epharmix

Epharmix was founded in 2015.

Epharmix is headquartered in St. Louis, United States. It is registered at St. Louis, Missouri, United States.

Epharmix is a funded company, having raised a total of $1.88M across 4 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $765K, raised on Jul 2015.

Epharmix was founded in 2015 and is based in St. Louis, United States, within the healthcare technology sector. A platform is offered that delivers communication tools to providers, including SMS and phone-based digital interventions for physicians. Automated calls and text messages are used to gather disease-specific patient data, which is then analyzed to triage entire patient panels and distribute tasks to medical staff.

Epharmix's top competitors include Slack, Webex and Bandwidth.

Epharmix has 3 investors. Key investors include Arch Grants, HealthX Ventures, and BioGenerator.

Epharmix operates through Epharmix, Inc..

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available